April 28, 2009 (FinancialWire) — Medical International Technology Inc. (OTC: MDLH) said it has received a $200,000 private placement from its future Chinese partners.

The company said that the financing is part of a joint venture agreement with the aim of developing and marketing Medical International’s “needle free” injection technology.

Medical International said that the technology is the outcome of more than twenty-eight years of research and development, and has resulted in product lines aimed at both humans and animals.

Denver-based Medical International Technology has subsidiary offices in Montreal, specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.